Logo.jpg
CAR T Cell Therapy Market To Reach USD 39.9 Billion By 2032, Says DataHorizzon Research
07 mai 2024 03h10 HE | DataHorizzon Research
Fort Collins, Colorado, May 07, 2024 (GLOBE NEWSWIRE) -- The growing prevalence of cancer is a prominent factor in the development of CAR T Cell therapy. The increasing prevalence of cancer...